A network meta-analysis of second-line immune checkpoint inhibitors and docetaxel for advanced non-small cell lung cancer: An economic evaluation from China

Precision Medication · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles